Carregant...

USP21 regulates Hippo pathway activity by mediating MARK protein turnover

The Hippo pathway, which acts to repress the activity of YAP and TAZ trancriptional co-activators, serve as a barrier for oncogenic transformation. Unlike other oncoproteins, YAP and TAZ are rarely activated by mutations or amplified in cancer. However, elevated YAP/TAZ activity is frequently observ...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Nguyen, Hung Thanh, Kugler, Jan-Michael, Loya, Anand C., Cohen, Stephen M.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5609986/
https://ncbi.nlm.nih.gov/pubmed/28969054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19322
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!